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Abstract
Background: Leptin and its soluble receptor (sOB-R) are important to regulation of body
composition but there are no data on the developmental variations in these plasma variables and
their relationship with body composition measurements,
Methods: Weight, length, and body composition (bone, fat and lean mass) by dual energy
absorptiometry, and plasma variables were measured in healthy infants at 2, 4, 8 and 12 months.
Results: 15 whites and 29 African Americans (21 males and 23 females) with mean birth weight
3357 +/- 45 (SEM) g and gestation of 39.3 +/- 0.17 weeks were studied. The overall Z score for
weight, length and weight for length during the study were 0.00 +/- 0.15, -0.08 +/- 0.11 and 0.12 +/
- 0.14 respectively. With increasing age, plasma leptin (1.0 to 18.2, median 5.5 ng/mL) and sOBR:leptin molar ratio (10.1 to 247.4, median 59.9) were lowered (r = -0.47, p < 0.01; and r = -0.37,
p < 0.05 respectively), best predicted by weight Z score and percentage of fat mass, and higher in
African American and female. Presence of body composition measurements eliminated the race
and gender effect on the plasma variables. Plasma sOB-R (49.5 to 173.9, median 81.3 ng/mL) did
not change significantly with age and was correlated and predicted only by body composition
measurements.
Conclusion: In healthy growing infants, plasma leptin but not sOB-R decreases with age. Gender,
race and anthropometric measurements are additional physiological determinants predictive of
plasma leptin and the receptor:ligand ratio. However, body composition is the only variable that
can predict plasma leptin and its soluble receptor and the receptor: ligand ratio; and body
composition measurements eliminated the race and gender effect on these plasma variables.

Background
Hormonal responses from the gastrointestinal tract, brain
and body tissues associated with dietary intake and regulation of nutritional status and body weight are well
described in adults [1-3]. There are increasing data indicating that similar hormonal changes can occur in children and infants [4-9]. Understanding their relationship

with body composition measurements as indicators of tissue accretion might shed light on the physiological basis
to integrate nutrition support, growth and tissue accretion.
Concentration of circulating leptin, an adipocyte hormone, reflects the amount of energy stored in adipose tisPage 1 of 7
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sue and is considered a marker of nutritional status [1-3].
Leptin is bound to the soluble leptin receptor (sOB-R) in
the circulation, which modulates steady state leptin levels
by preventing the hormone from degradation and clearance [10], and sOB-R:leptin ratio may be considered a
marker of bioavailable leptin.
In the neonate, dramatic changes in circulating leptin and
sOB-R with a decrease in leptin by as much as 80% [5-7]
and increase in sOB-R by >5 folds [7] are reported. At
birth, weight and body mass index are positively correlated with plasma leptin concentrations [5,6,8], and one
report indicated that sOB-R is inversely related to birth
weight [7]. This pattern of changes in leptin and its sOB-R
and their relationship with body weight and body mass
index presumably reflect the loss of placental contribution for leptin and the physiologic adaptation to lower
availability of free leptin, thereby allowing an increase in
energy intake to initiate the phase of rapid postnatal
growth.
Infancy is the period of most rapid postnatal growth and
one report in healthy but relatively malnourished infants
with average weight for age Z score of -1.9 at 52 weeks
shows a decrease in plasma leptin from birth to 1 year.
Changes in plasma sOB-R in infants beyond the immediate newborn period are not well defined. Furthermore, the
relationship between body composition measurements as
reflection of tissue accretion, with these plasma variables
is not known. The aim of this study is to define the developmental variations in circulating leptin and sOB-R in
healthy infants specifically the physiologic determinants
including age, gender, race, and measures of growth or
body composition on these plasma variables.

Methods
This is a cross sectional design with anthropometry, body
composition and circulating leptin and sOB-R measurements performed on the same day for each subject. All
subjects were singleton infants between 37 and 42 weeks
gestation with appropriate birth weight for gestation [11]
and studied at approximately 2, 4, 8 and 12 months.
None of the infants had major malformation or medical
or surgical conditions that may affect long term growth.
Weight, length, and head circumference were measured
using standard methods [12,13]. Infants were weighed in
the nude to the nearest 5 g using an electronic scale (Seca,
Toledo, OH) that was calibrated daily. Length was measured in duplicate to the nearest 0.1 cm with the infant in
a recumbent position using O'Leary Lengthboard ™
(Ellard Instruments Ltd, Seattle, WA).
Body composition is indicated by total body bone mass as
bone mineral content, and fat and lean mass were deter-
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mined by fan beam dual energy X-ray absorptiometry
(DXA) (QDR 4500A, Hologic Inc, Waltham, MA). Scan
acquisition techniques have been reported elsewhere [14].
Each infant was wrapped in cotton blanket for the scan.
The use of a diaper with or without light undergarment for
the infant was allowed prior to bundling the infant in the
cotton blanket. However, all coverings were weighed with
an electronic scale and the weight recorded. Scan analysis
used software vKHS11 validated by carcass analysis
[15,16]. Only scans with no significant movement artifacts [17] were included in data analysis. In our laboratory, the precision error [18] from duplicate infant whole
body scans for bone, fat and lean mass were 2.6, 7.1 and
2.5% respectively. Bone, fat and lean mass also were
expressed as a percent of DXA measured total body mass.
Plasma samples for the measurement of leptin and sOB-R
were kept at -70°C until measurement. Plasma leptin and
sOB-R were measured using the commercial enzyme
linked immunoassay kits from the same manufacturer
(Diagnostic Systems Laboratories, Inc., Webster, TX).
Recombinant human leptin and human soluble leptin
receptor were used as standards and controls in the respective assays. In our laboratory, the coefficient variation of
the leptin assay was 9% and for the sOB-R assay was 5%.
Ethical approval for the study was obtained from the Institutional Review Board for Human Investigations at Wayne
State University, Detroit, MI. Written informed consent
was obtained from the parent of each infant.
Statistical analysis
The absolute values of anthropometric measurements
were normalized by expression as Z scores using the age
and gender matched normative data from the National
Center for Health Statistics [19]. The absolute values for
bone, fat and lean mass were transformed to a percentage
of total weight. Plasma sOB-R:leptin molar ratio was calculated according to the molecular mass of 130 kD for
sOB-R and 16 kD for leptin. All statistical analysis
included the use of absolute and transformed measurements.

Pearson's correlation was used to determine the relationship for each plasma parameter (leptin, sOB-R and sOBR:leptin ratio) with each anthropometric and each DXA
parameter. Analysis of covariance was used to determine
the relation of gender, race and age to plasma measurements. Stepwise regression analysis was used to determine
the relative contribution from each of the physiologic variables in the prediction of plasma leptin, sOB-R, and sOBR:leptin ratio. By design, the use of absolute and percentage of body composition measurement was mutually
exclusive in regression analysis, as well as the use of
anthropometric and DXA measurements, since body
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weight is the sum of body composition measurements;
and both weight and length are predictive of various
aspects of body composition [20-22]. Neither age nor gender was entered as independent variables with any analysis using Z scores since the Z scores were standardized to
age and gender.
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Table 1: Correlation of plamsa leptin, leptin soluble receptor
(sOB-R), and sOB-R:Leptin ratio with anthopometric
measurements and their Z scores in term infants

Leptin ng/mL

All values are mean +/- SEM. Statistical tests were performed with SPSS Version 13.5 for Windows (SPSS Inc.,
Chicago, IL) at an adopted significance level of 0.05 and
were two-tailed.

Weight
Length
Weight:length ratio

Results

Weight
Length
Weight for length

There were 44 infants with mean birth weight 3357 +/- 45
g and gestation of 39.3 +/- 0.17 weeks, with 15 whites and
29 African Americans, and 21 (7 white) males and 23 (8
white) females. Anthropometric and DXA measurements
and blood collection were performed at 56 +/- 0.8, 112 +/
- 1.0, 240 +/- 1.5, and 366 +/- 2.7 days. Age was positively
correlated with all absolute values of anthropometric and
DXA measurements (p < 0.01 for all comparisons).
Weight for age Z score (WAZ) decreased (r = -0.36, p =
0.02) but recumbent length for age (HAZ) and weight for
length (WHZ) Z scores were not significantly different
with age. The overall WAZ, HAZ and WHZ were 0.00 +/0.15 and -0.08 +/- 0.11, and 0.12 +/- 0.14 respectively.
Bone mass as a percentage of total mass was increased (r
= 0.58, p < 0.01) but the percentages of fat and lean mass
did not change significantly with age. The overall percentages for bone, fat and lean mass were 2.5 +/- 0.04, 26.3 +/
- 0.92, and 71.2 +/- 0.93 respectively.
Plasma leptin concentrations varied from 1.0 to 18.2
(median 5.5) ng/mL and decreased with age (r = -0.47, p
< 0.01) (Fig 1). The relationships between plasma leptin
concentrations and anthropometric measurements are
shown in Table 1. Z scores were better correlated with
plasma leptin than absolute measurements. The relationships between plasma leptin concentrations and body
composition measurements are shown in Table 2. Body
compositions as percentage of total weight were better
correlated with plasma leptin than absolute measurements. Percent fat mass was positively correlated with
plasma leptin although both absolute and percent bone
and lean masses were negatively correlated with plasma
leptin. African American infants had higher plasma leptin
concentrations (p < 0.05) after adjustment for age at
study. There was no race and gender interaction effect on
plasma leptin. Neither race nor gender affected absolute
or percent fat mass.
Plasma sOB-R concentrations varied from 49.5 to 173.9
(median 81.3) ng/mL, did not change significantly with
age (Fig 2) and were not significantly correlated with
plasma leptin concentrations. There was no correlation

Leptin soluble
receptor ng/mL

sOBR:Leptin
molar ratio

Absolute measurements
-0.29
0.29
-0.44*
0.23
0.45*
-0.25
Z scores
0.58*
0.22
0.05
0.29
0.57*
0.17

-0.14
-0.30
0.30
0.66*
0.21
0.62*

Pearson correlation with 2 tailed significance: * p ≤ 0.01

between plasma sOB-R with any anthropometric measurements (Table 1). Plasma sOB-R was positively correlated with fat mass and negatively correlated with percent
lean mass (Table 2). Plasma sOB-R was not affected by
race or gender.
Plasma sOB-R:leptin molar ratio varied from 10.1 to
247.4 (median 59.9) and decreased with age (r = -0.37, p
= 0.05). Weight and WAZ were the only anthropometric
variables significantly correlated with plasma sOB-R:leptin ratio. Whereas, plasma sOB-R:leptin ratio was positively correlated with absolute and percent fat mass, but
negatively correlated with lean mass and percent lean and
bone mass. The relationship was stronger based on percent lean or fat mass than the absolute mass (Table 2).
There was no race or gender effect on plasma sOB-R:leptin
ratio.
Weight or WAZ had positive and length or HAZ had negative predictive effect on plasma leptin. Females have
higher plasma leptin concentrations and sOB-R:leptin
ratio compared to males. None of the physiologic variaTable 2: Correlation of plasma leptin, leptin soluble receptor
(sOB-R), and sOB-R:Leptin ratio with body composition
measurements as absolute values or as percentage of total
weight in term infants

Leptin ng/mL

Leptin soluble receptor
ng/mL

Absolute measurements
Bone
-0.32†
Lean
-0.43*
Fat
0.16
As percentage of total weight
Bone
-0.33†
Lean
-0.50*
Fat
0.52*

sOB-R:Leptin
molar ratio

0.20
0.17
0.47*

-0.21
-0.34†
0.38†

-0.16
-0.33†
0.31

-0.33†
-0.66*
0.66*

Pearson correlation with 2 tailed significance: * p ≤ 0.01, † p ≤ 0.05
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Figure
Variation in plasma leptin concentrations with age in healthy
infants.

bles entered into analysis with anthropometric measurements were predictive for plasma soluble receptor
concentration (Table 3).
The absolute or percent fat mass was consistently predictive of plasma leptin, sOB-R and sOB-R:leptin molar ratio
(Table 4). Percentage of body composition component
was slightly better than the absolute values in the prediction of the plasma variables. Age was predictive of plasma
leptin and sOB-R:leptin ratio. Presence of body composition measurements eliminated any race or gender effect
on plasma sOB-R and sOB-R:leptin ratio.

180
160

N = 36
r = 0.15, p = NS

Study of leptin and its regulation has demonstrated its
importance as an integral part of homeostatic mechanism
in the regulation of body weight [1-3]. However, it is not
known whether this is applicable to all life stages and
what changes it may have during growth in which weight
gain and tissue accretion rather than maintenance of body
weight is the physiologic norm.
To our knowledge, this is the first report of the relationship of the circulating leptin and sOB-R concentrations to
various physiological variables of growth and body composition specifically, bone, fat and lean masses, during
infancy. Age appears to be a major physiologic determinant of plasma leptin concentrations. It is decreased during infancy in those with normal age and gender specific
weight and length Z scores as indicated by our data, and is
also decreased in infants with poor postnatal growth during longitudinal measurement of plasma leptin from cord
blood and at 8, 16 and 52 weeks [9]. In this study, the initial measurement of circulating leptin and its soluble
receptor at 2 months likely eliminated the confounding
factors of placental leptin [23], the initial physiologic
adaptation that occurs commonly with other endocrine
systems [24], and the apparent transient increase in
plasma leptin during the first weeks after birth observed
by some [25,26] but not by other [9] investigators. In the
two reports on postnatal increase in plasma leptin concentration, one reported an increase in plasma leptin at 30
days which was significantly correlated with interval
weight gain [25] but no data was available beyond 30
days. In the other report, plasma leptin concentration was
higher in term versus preterm infants up to 30 days but
there was no significant difference between groups at 90
days. The increase in plasma leptin was correlated with
weight gain and increase in subcutaneous tissue [26].
Whether this transient increase in plasma leptin is related
to changes in leptin transport, metabolism or clearance is
not known.

sOB-R ng/ml

140
120
100
80
60
40
0

100

200

300

400

Age (days)

Figure 2with
Variation
trations
in plasma
age in leptin
healthysoluble
infantsreceptor (sOB-R) concenVariation in plasma leptin soluble receptor (sOB-R) concentrations with age in healthy infants.

Plasma sampling in our study tend to correspond to ages
when milk intake is the exclusive or dominant source of
nutrient, namely at 2 and 4 months, and when mixed diet
becomes increasingly established at 8 and 12 months
respectively. Our preliminary data suggest that usual dietary intake in healthy and normally grown infants probably does not affect plasma leptin or its soluble receptor
concentrations, although determination of the relationship between leptin and its receptor with details of nutritional intake was not the primary goal of this study and
further studies are needed.
Anthropometric and body composition measurements
are related to and predictive of plasma leptin. This is consistent with other reports that plasma leptin is correlated
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Table 3: Prediction values of physiologic variables including age, race, gender, and absolute values (left 2 columns) or age and gender
specific Z scores (right 2 columns) of anthropometric measurements for plasma concentrations of leptin and leptin soluble receptor*,
and leptin soluble receptor:leptin molar ratio.

Dependent variable – plasma leptin (ng/mL)
Independent variables: R2 0.49
Weight (g)
Length (cm)
Gender (Female = 1, male = 0)

Beta (p)
1.87 (0.001)
-2.17 (0.001)
0.27 (0.03)

Dependent variable – plasma soluble leptin receptor : leptin molar ratio
Independent variables: R2 0.50
Age (d)
-0.75 (0.001)
Weight (g)
1.51 (0.001)
Gender (Female = 1, male = 0)
0.39 (0.01)

Independent variables: R2 0.46
Weight Z score
Length Z score

Beta (p)
0.83 (0.001)
-0.44 (0.01)

Independent variables: R2 0.44
Weight Z score

0.66 (0.001)

* None of the physiologic variables was predictive for plasma soluble receptor concentration.

with actual [26] or gain [25,26] in body weight, and actual
[8,9] and changes [9] in body mass index, and with indirect indicators of body fat such as subcutaneous skinfold
thicknesses [7,25,26]. Plasma leptin was also found to discriminate both the long term and changes in energy status
based on skinfold thickness [9].
The consistent relation between the plasma leptin particularly with fat mass is supportive of adipose tissue being
the major source of circulating leptin. The negative correlation of percent bone mass and percent lean mass with
plasma leptin is not surprising since an increase in the
proportion of fat mass is generally correlated with
decreased proportion of lean and bone mass. However, a
direct relation between plasma leptin and other tissue
mass may be possible since increasing numbers of nonadipose tissues including skeletal muscle [27], chondrocyte [28] and human osteoblast [29] are reported to synthesize leptin and may have cellular leptin receptor forms

with physiological activity in experimental models. In any
case, the exact role of leptin in the changes in skeletal muscle and bone in humans remain to be defined.
Our data show elevated sOB-R concentrations throughout
infancy. Other investigators have reported persistently elevated sOB-R concentrations during early childhood [30].
The positive relation between plasma sOB-R and fat mass
may be indicative of the increased membrane-bound leptin receptor forms, the source of sOB-R. The negative correlation of percent lean mass with plasma sOB-R is
consistent with the generally inverse relation between percent lean and fat mass.
The correlation between these plasma variables with
anthropometric or body composition measurements were
better with the use of Z scores rather than absolute measurements, with fat percent rather than absolute fat mass,
and generally better with body composition, specifically

Table 4: Prediction values of physiologic variables including age, race, gender, and absolute values (left 2 columns) or percent bone,
lean and fat mass (right 2 columns) for plasma leptin and leptin soluble receptor concentrations, and leptin soluble receptor:leptin
molar ratio

Dependent variable – plasma leptin (ng/mL)
Independent variables: R2 0.37
Age (d)
Fat (g)

Beta (p)
-0.65 (0.001)
0.44 (0.003)

Dependent variable – plasma soluble leptin receptor (ng/mL)
Independent variables: R2 0.22
Fat (g)
0.47 (0.004)

Dependent variable – plasma soluble leptin receptor : leptin ratio
Independent variables: R2 0.54
Age (d)
-0.71 (0.001)
Fat (g)
0.72 (0.001)

Independent variables: R2 0.37
Age (d)
Fat%

Beta (p)
-0.34 (0.01)
0.42 (0.003)

Independent variables: R2 0.43
BMC%
Lean%
Fat%

-0.63 (0.004)
-14.1 (0.001)
-13.8 (0.001)

Independent variables: R2 0.59
BMC%
Lean%
Fat%

-0.59 (0.002)
-7.04 (0.02)
-6.42 (0.03)
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fat mass, rather than anthropometric measurements. Thus
the use of standardized rather than absolute measurements of anthropometry and body composition is indicated in future studies on the interplay of leptin and its
receptor with different nutrition support in growing subjects. Furthermore, body composition measurements are
probably more sensitive indicators of leptin production
and bioactivity.

http://www.nutritionj.com/content/6/1/11

age. Body composition is the only variable that can predict plasma leptin and its soluble receptor and the receptor:ligand ratio, and body composition measurements
eliminate the race and gender effect on these plasma variables. Based on limited size of subgroups in this study, the
race and gender effect on these plasma variables appears
to be consistent with that for adults.
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